[Frequency of silent and painful ischemia in patients with treated stable coronary insufficiency]
C Caussé1, J P Marcantoni, F A Allaert
1Laboratoires Pierre Fabre Cardiovasculaire, La Chartreuse, 81106 Castres, France.
Insights
Silent myocardial ischemia is common in stable coronary disease patients, often occurring without symptoms. Longer monitoring is crucial for detecting this silent condition, which may increase mortality risk.
Area of Science:
- Cardiology
- Clinical Research
Background:
- Stable coronary disease patients frequently experience myocardial ischemia.
- Distinguishing between symptomatic and silent ischemia is critical for risk assessment.
Purpose of the Study:
- To determine the frequency and circadian variations of symptomatic and silent myocardial ischemia.
- To compare ischemic episodes in symptomatic versus asymptomatic patients.
- To identify factors associated with silent ischemia.
Main Methods:
- 1,088 ambulatory patients with stable coronary disease were monitored for 4 days using portable electrocardiographic recorders.
- Patients could voluntarily activate recorders during cardiac discomfort.
- Data were validated by cardiologists.
Main Results:
- Over 95,725 hours of monitoring, 3,258 ischemic episodes were recorded.
- 91% of episodes (2,963) were silent ischemia; 9% (295) were symptomatic.
- 148 patients (54.6%) experienced only silent ischemia; 63% of these would have been missed with 24-hour monitoring.
- Factors like hypertension and renal failure correlated with increased silent ischemia.
Conclusions:
- Silent myocardial ischemia is numerically significant in stable coronary disease.
- Extended monitoring duration is necessary for effective detection of silent ischemia.
- Identifying at-risk individuals for silent ischemia may improve mortality outcomes.
Abstract:
The present study was aimed at determining the frequency and circadian variations in symptomatic or silent myocardial ischemia in ambulatory patients with stable coronary disease. A comparative analysis was then made of the recordings on symptomatic and asymptomatic patients according to their medical history. Three hundred and twenty-one cardiologists recruited a total of 1,088 patients who were monitored for 4 days with a new type of electrocardiographic recorder. The patients were able to voluntarily start up the recorder in the case of cardiac discomfort or pain. The results showed that over a total recording period of 95,725 hours, the following data, which were validated by an experienced cardiologist, were obtained: 3,258 ischemic episodes, 2,963 (or 91%) of which were cases of silent ischemia, and 295 (or 9%) which were symptomatic. All the ischemic episodes involved a limited number of subjects, i.e., 271 patients. Of these, 148 (54.6%) were completely asymptomatic; only 63% of these patients with silent ischemia would have been detected if the recording had just lasted 24 hours. Moreover, the medical history showed a correlation between certain factors (such as poorly managed arterial hypertension, cardiac insufficiency, renal failure, arteritis of the lower limbs, and a waist-hip relation of over one in men) and an increase in the number of cases of silent ischemia. However, no single factor was found to be linked more to silent ischemia than to symptomatic ischemia. This investigation therefore shows the significant numeric incidence of silent ischemia. It raises the question of the need to prescribe treatment in at-risk subjects which includes recordings of long duration, so that silent ischemia, which may increase the risk of mortality, can be more readily detected.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation


